Please join us at for our annual Swedish IBD update on Friday, June 1st, 2024!
The annual Swedish Providence Update in Inflammatory Bowel Disease course will review new and forthcoming medical and surgical therapeutic approaches in IBD and its associated manifestations, as well their impact on the current management of these conditions. The therapeutic landscape in IBD continues to evolve, resulting in rapid and dramatic changes to therapeutic algorithms and disease monitoring. The course will review the impact of positioning new therapeutics, optimization of medical therapy, disease management in the perioperative period, extraintestinal manifestations, dietary, nonpharmacologic therapies and multi-disciplinary approaches to complex clinical scenarios including strictures. It will also cover novel therapies including the advent of small molecules and their impact in the management of IBD patients.
Teaching methods include lecture/didactic, Q&A with faculty, panel discussion, case presentation and audience response system.
This year's keynote speaker is Dr. Millie Long, Associate Professor of Medicine, Division of Gastroenterology and Hepatology at University of North Carolina School of medicine. She is board certified in internal medicine, preventive medicine and gastroenterology. Her clinical practice is based at the UNC Inflammatory Bowel Diseases Center.
At the conclusion of this activity, participants should be able to:
- Name current trends in the diagnosis and management of IBD
- Critically appraise and implement evidence-based management pathways for patients with Crohn’s disease
- Critically appraise and implement evidence-based management pathways for patients with ulcerative colitis
- Understand the choice of first and second line therapy for patients with IBD based on risk factors, comorbidities and extraintestinal manifestations
- Learn an evidence-based approach to patients with Crohn’s disease and peri-anal fistulas
- Review evolving treatment modalities for patients with peri-anal Crohn’s disease
- Understand the rationale and practical aspects of therapeutic drug monitoring in practice
- Understand the merits and limitations of proactive and retroactive TDM
- Learn aspects of nutrition as a complementary approach and therapy for IBD
- Review evolving trends in applying artificial intelligence in endoscopy
- Understand the differences in surgical techniques for Crohn’s disease
- Learn about the importance of mental health as a determinant of quality care in IBD
Who Should attend
Medical Professionals in:
- General Practice
- Internal Medicine
- OBGYN / Obstetrics & Gynecology
- Colorectal Surgery
- General Surgery
*2022 Accreditation is displayed for reference. Please check back for updates.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Well Assembled Meetings. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs may claim a maximum of 7.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
2024 Agenda (All times shown in Pacific Time Zone)